共 50 条
- [5] Improved safety of basiliximab (Simulect®) over antithymocyte globulin (Thymoglobulin®) induction therapy in heart transplantation [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S62 - S62
- [8] Induction With Anti-Thymocyte Globulin After Heart Transplantation Is Associated with Better Long-term Survival Compared to Basiliximab [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S145 - S145